Clinical Study

Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial

Figure 1

Treatment difference (95% CI) of SPC T80/H25 versus T80 for changes in mean seated trough cuff (a) SBP and (b) DBP from baseline to Week 7 by patient subgroup (FAS). BMI: body mass index; CHD: coronary heart disease; CI: confidence interval; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; FAS: full analysis set; H25: hydrochlorothiazide 25 mg; SBP: systolic blood pressure; SPC: single-pill combination; T80: telmisartan 80 mg.
749830.fig.001a
(a)
749830.fig.001b
(b)